Irina Rivkind Koffler


Mizuho Forecasts 127% Upside for Adamas Pharmaceuticals Inc (ADMS) Following Higher-Than-Anticipated Gocovri Pricing

Analyst nearly doubles price target between Gocovri pricing and better prospects in Multiple Sclerosis arena.

Adamas Pharmaceuticals Inc’ (ADMS) Gocovri Has Mizuho Confident Following Favorable Expert Call

Lead asset for ADMS indicates promising prospects in Parkinson’s along with valuable opportunity in MS.

Time to Cut Loose from Valeant Pharmaceuticals Intl Inc (VRX)

Irina Rivkind Koffler Doubles Down on Bearish Bet

Mizuho Applauds Adamas Pharmaceuticals Inc (ADMS) on Surprise Home Run for Gocovri as Shares Jet 47%

Adamas Puts CRL Fears to Rest with Gocovri (Amantadine) Approval

Mizuho Still Not Expecting a Turnaround for Valeant Pharmaceuticals Intl Inc (VRX), Neutral on Depomed (DEPO)

Mizuho analyst Irina Rivkind Koffler came out today with new research notes on a handful of biotechnology stocks. Let’s take a look and …

Mizuho Top Analyst Buzzes Mayday as Eagle Pharmaceuticals Inc (EGRX) Valuation Likely to Collapse

Eagle Pharmaceuticals Inc (NASDAQ:EGRX) shares are on an almost 24% cave-in today after the biotech firm’s leading pipeline program, the one the Eagle …

Top Analyst Loses Confidence in Horizon Pharma PLC (HZNP)

Horizon Pharma PLC (NASDAQ:HZNP) investors scurried sending shares crashing 35% yesterday once the biotech firm released disappointing first quarter earnings for the year …

Valeant Pharmaceuticals Intl Inc (VRX) Refinancing Not a Surprise and Certainly Not Good News

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares are tumbling 6% today on the heels of a debt refinancing reveal that could simultaneously lift interest …

Top Analyst Boosts Price Target on Endo International plc – Ordinary Shares (ENDP), Sees Upside for the Stock

Top analyst Irina Rivkind Koffler at Mizuho is all the more bullish on Endo International plc – Ordinary Shares (NASDAQ:ENDP) following the subdued …

Valeant Pharmaceuticals Intl Inc (VRX): What This Top Analyst Is Saying

Though Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares were surging nicely ahead at almost 6% yesterday, and continuing to rise today, top analyst Irina …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts